Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS EQUITY (DEFICIT) (Details 4)

v3.24.3
STOCKHOLDERS EQUITY (DEFICIT) (Details 4)
9 Months Ended
Sep. 30, 2024
$ / shares
shares
Number of exercisable Register warrant 495,917
Number of exercisable options 495,917
Weighted average exercise price exercisable term 1 year 8 months 1 day
Weighted average exercise price exercisable | $ / shares $ 33.00
Registered Warrant | 33.00  
Exercise price range 33.00
Number of exercisable Register warrant 495,917
Number of exercisable options 495,917
Weighted average exercise price exercisable term 1 year 8 months 1 day
Weighted average exercise price exercisable | $ / shares $ 33.00